SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The Total revenue for the quarter ended December 2025 of  Rs. 5288.00 millions remain, more or less, the same.The Company's Net profit for the December 2025 quarter have declined marginally to Rs. 338.40  millions as against Rs. 385.30 millions reported during the corresponding quarter ended.The Operating Profit of the company witnessed a decrease to 435.30 millions from 716.20 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202512 202412 % Var 202512 202412 % Var 202503 202403 % Var
Sales 5288.00 5145.40 2.77 16287.10 15505.90 5.04 21736.50 22669.10 -4.11
Other Income 12.20 113.70 -89.27 17.50 118.60 -85.24 135.80 41.80 224.88
PBIDT 435.30 716.20 -39.22 1832.00 1858.70 -1.44 2762.30 2703.10 2.19
Interest 69.50 75.70 -8.19 197.80 222.00 -10.90 296.80 301.60 -1.59
PBDT 365.80 640.50 -42.89 1634.20 1636.70 -0.15 2465.50 2401.50 2.67
Depreciation 148.70 120.20 23.71 406.90 355.90 14.33 477.90 476.70 0.25
PBT 217.10 520.30 -58.27 1227.30 1280.80 -4.18 1987.60 1924.80 3.26
TAX -121.30 135.00 -189.85 -15.30 322.50 -104.74 414.50 506.00 -18.08
Deferred Tax 22.50 15.00 50.00 62.50 40.00 56.25 35.00 10.00 250.00
PAT 338.40 385.30 -12.17 1242.60 958.30 29.67 1573.10 1418.80 10.88
Equity 912.70 912.70 0.00 912.70 919.40 -0.73 912.70 919.40 -0.73
PBIDTM(%) 8.23 13.92 -40.86 11.25 11.99 -6.16 12.71 11.92 6.57

Aarti Drugs Share Price

380.00 4.95 (1.32%)
05-Jun-2026 10:07 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1788.20
Dr. Reddys Lab 1270.15
Cipla 1390.50
Zydus Lifesciences 1090.25
Lupin 2275.05
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×